Steward Partners Investment Advisory’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-100
| Closed | -$2 | – | 3627 |
|
|
2023
Q3 | $2 | Hold |
100
| – | – | ﹤0.01% | 3376 |
|
|
2023
Q2 | $21 | Hold |
100
| – | – | ﹤0.01% | 3304 |
|
|
2023
Q1 | $16 | Hold |
100
| – | – | ﹤0.01% | 3294 |
|
|
2022
Q4 | $56 | Hold |
100
| – | – | ﹤0.01% | 3313 |
|
|
2022
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 3450 |
|
|
2022
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 3429 |
|
|
2022
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 3418 |
|
|
2021
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 3366 |
|
|
2021
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 3396 |
|
|
2021
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 7490 |
|
|
2021
Q1 | $323 | Hold |
100
| – | – | ﹤0.01% | 3361 |
|
|
2020
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 3026 |
|
|
2020
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 2891 |
|
|
2020
Q2 | $0 | Sell |
100
-1,500
| -94% | -$1.43K | ﹤0.01% | 2782 |
|
|
2020
Q1 | $1K | Hold |
1,600
| – | – | ﹤0.01% | 2448 |
|
|
2019
Q4 | $1K | Hold |
1,600
| – | – | ﹤0.01% | 2551 |
|
|
2019
Q3 | $1K | Hold |
1,600
| – | – | ﹤0.01% | 2572 |
|
|
2019
Q2 | $2K | Buy |
+1,600
| New | +$2.58K | ﹤0.01% | 2482 |
|
|
2018
Q4 | – | Sell |
-2,580
| Closed | -$7K | – | 2314 |
|
|
2018
Q3 | $7K | Hold |
2,580
| – | – | ﹤0.01% | 2039 |
|
|
2018
Q2 | $5K | Hold |
2,580
| – | – | ﹤0.01% | 2028 |
|
|
2018
Q1 | $5K | Hold |
2,580
| – | – | ﹤0.01% | 1822 |
|
|
2017
Q4 | $5K | Buy |
2,580
+1,600
| +163% | +$3.32K | ﹤0.01% | 1537 |
|
|
2017
Q3 | $1K | Sell |
980
-372
| -28% | -$462 | ﹤0.01% | 1625 |
|
|
2017
Q2 | $2K | Hold |
1,352
| – | – | ﹤0.01% | 1463 |
|
|
2017
Q1 | $4K | Buy |
+1,352
| New | +$3.33K | ﹤0.01% | 1198 |
|
Other funds holding INFI
Steward Partners Investment Advisory's INFI Position: Q4 2023 in Review
Steward Partners Investment Advisory sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2023, closing a stake of 100 shares — an estimated $2 sold.
Steward Partners Investment Advisory first reported a position in INFI in Q1 2017 and held it in 25 quarters. The position peaked at $7K in Q3 2018. 3 funds tracked by Wall St. Rank hold INFI as of Q4 2023.
- Steward Partners Investment Advisory reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Steward Partners Investment Advisory sold 100 Infinity Pharmaceuticals, Inc. shares in Q4 2023, an estimated $2.
- Steward Partners Investment Advisory first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2017 and held it in 25 quarters.
- Steward Partners Investment Advisory's Infinity Pharmaceuticals, Inc. position peaked at $7K in Q3 2018.
- 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2023.
Based on Steward Partners Investment Advisory's 13F filing for Q4 2023, filed 12 Feb 2024.